Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and inspiring, ...
The U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages ...
The Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial virus (RSV) vaccine for use ...
An ongoing study showed that 60% of lung cancer patients who took a drug called Lorbrena remained alive and disease-free ...
AstraZeneca unveiled promising new data for two of its cancer drugs — Enhertu and Tagrisso — giving the pharma giant the ...
Explore the latest breakthroughs in cervical cancer treatment, including Pfizer's Tivdak, recently approved by U.S.
Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a ...
Cathie Wood, the widely known founder and CEO of ARK Invest, has garnered a reputation for her forward-thinking investment ...
This summary highlights key events in the health sector, including the mixed results of Gilead's Trodelvy in cancer trials, ...
This health news summary spotlights major developments in cancer treatments, regulatory actions on biotechnology, and the ...
(Photo by Larry Luxner) This year’s CureDuchenne Futures conference is the first at which an approved ... Pfizer reported that a 3-year-old boy enrolled in the company’s phase 3 Daylight study who had ...
the first approved gene therapy for Duchenne. Elevidys is currently only available for certain 4- to 5-year-old boys under an conditional approval granted by the FDA last June. By June 21 ...